Combination Therapy Prevents the Relapse of RA

NCT02320630 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Recurrence (Disease Attribute)

Interventions

DRUG: Entanercept
DRUG: HCQ
DRUG: MTX

Sponsor

Peking University First Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]